Balyasny Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9,238
| Closed | -$234K | – | 1934 |
|
|
2024
Q2 | $234K | Buy |
+9,238
| New | +$234K | ﹤0.01% | 1668 |
|
|
2024
Q1 | – | Sell |
-14,605
| Closed | -$331K | – | 1959 |
|
|
2023
Q4 | $331K | Buy |
14,605
+4,551
| +45% | +$103K | ﹤0.01% | 1571 |
|
|
2023
Q3 | $187K | Buy |
+10,054
| New | +$187K | ﹤0.01% | 1563 |
|
|
2018
Q3 | – | Sell |
-12,769
| Closed | -$409K | – | 1416 |
|
|
2018
Q2 | $409K | Buy |
12,769
+7,969
| +166% | +$255K | ﹤0.01% | 1230 |
|
|
2018
Q1 | $239K | Sell |
4,800
-3,700
| -44% | -$184K | ﹤0.01% | 1506 |
|
|
2017
Q4 | $458K | Buy |
+8,500
| New | +$458K | ﹤0.01% | 1336 |
|
|
2017
Q1 | – | Sell |
-7,923
| Closed | -$388K | – | 1388 |
|
|
2016
Q4 | $388K | Buy |
7,923
+923
| +13% | +$45.2K | ﹤0.01% | 999 |
|
|
2016
Q3 | $335K | Buy |
+7,000
| New | +$335K | ﹤0.01% | 772 |
|